Cingulate stock skyrockets after ADHD treatment shows positive trial results

Shares of Cingulate Inc. CING, +51.30% skyrocketed 82.9% toward an 11-month high in active premarket trading Friday, after the biopharmaceutical company reported positive results from a trial of its a...